MedTrace Logo

Corticosteroid Pulse After Ablation

NCT00807586 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2019-08-20

Study results available
· View outcomes & findings →

Summary

Radiofrequency ablation is an effective treatment for atrial fibrillation. However, about 20% of the time the atrial fibrillation recurs. Steroids given after the ablation may decrease inflammation caused by the ablation and thus improve healing and decrease the chance of recurrence of atrial fibrillation.

In this study patients will be randomized to receive intravenous steroids or not immediately following the ablation.

Conditions

Interventions

DRUG

Solumedrol

100mg, given once within 2 hours of the end of the ablation procedure

DRUG

Placebo

Normal saline (1.6 cc)

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Minneapolis Heart Institute Foundation

    lead OTHER

Principal Investigators

  • Daniel P Melby, MD · Minneapolis Heart Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00807586 on ClinicalTrials.gov